Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 7 | 2022 | 218 | 1.400 |
Why?
|
| Blood Vessel Prosthesis Implantation | 6 | 2022 | 208 | 1.320 |
Why?
|
| Aortic Aneurysm, Abdominal | 5 | 2022 | 112 | 1.260 |
Why?
|
| Pseudomonas aeruginosa | 5 | 2012 | 194 | 1.000 |
Why?
|
| Pseudomonas Infections | 4 | 2012 | 95 | 1.000 |
Why?
|
| Aneurysm | 1 | 2013 | 58 | 0.450 |
Why?
|
| Peritonitis | 1 | 2012 | 29 | 0.430 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 59 | 0.420 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 88 | 0.420 |
Why?
|
| Adhesins, Bacterial | 1 | 2012 | 36 | 0.420 |
Why?
|
| Sepsis | 3 | 2012 | 306 | 0.420 |
Why?
|
| Lectins | 1 | 2012 | 84 | 0.410 |
Why?
|
| Blood Vessel Prosthesis | 5 | 2022 | 228 | 0.410 |
Why?
|
| Hepatectomy | 1 | 2012 | 166 | 0.400 |
Why?
|
| Morphine | 1 | 2012 | 130 | 0.390 |
Why?
|
| Intestines | 3 | 2012 | 411 | 0.380 |
Why?
|
| Aortic Rupture | 2 | 2020 | 55 | 0.370 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2022 | 87 | 0.370 |
Why?
|
| Popliteal Artery | 2 | 2023 | 27 | 0.350 |
Why?
|
| Postoperative Complications | 4 | 2023 | 2207 | 0.340 |
Why?
|
| Stents | 3 | 2022 | 377 | 0.310 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 413 | 0.300 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 797 | 0.290 |
Why?
|
| Prosthesis Design | 4 | 2022 | 278 | 0.280 |
Why?
|
| Saphenous Vein | 1 | 2023 | 61 | 0.230 |
Why?
|
| Random Allocation | 3 | 2012 | 332 | 0.230 |
Why?
|
| Virulence | 3 | 2012 | 271 | 0.220 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2020 | 7 | 0.190 |
Why?
|
| Situs Inversus | 1 | 2020 | 13 | 0.190 |
Why?
|
| Aortography | 1 | 2020 | 63 | 0.190 |
Why?
|
| Jehovah's Witnesses | 1 | 2020 | 18 | 0.190 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 58 | 0.190 |
Why?
|
| Upper Extremity | 1 | 2020 | 52 | 0.190 |
Why?
|
| Aortic Aneurysm | 1 | 2020 | 80 | 0.180 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 165 | 0.170 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 131 | 0.170 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 466 | 0.150 |
Why?
|
| Vascular Surgical Procedures | 2 | 2023 | 148 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 860 | 0.150 |
Why?
|
| Treatment Outcome | 5 | 2022 | 7993 | 0.140 |
Why?
|
| Phosphates | 3 | 2012 | 160 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 579 | 0.140 |
Why?
|
| Caenorhabditis elegans | 3 | 2012 | 223 | 0.120 |
Why?
|
| Mice | 6 | 2012 | 11352 | 0.120 |
Why?
|
| Brachial Artery | 1 | 2013 | 36 | 0.110 |
Why?
|
| Physicians | 1 | 2021 | 673 | 0.110 |
Why?
|
| Femoral Artery | 1 | 2013 | 81 | 0.110 |
Why?
|
| Risk Factors | 5 | 2022 | 5417 | 0.110 |
Why?
|
| Aneurysm, False | 1 | 2013 | 54 | 0.110 |
Why?
|
| Axilla | 1 | 2013 | 99 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2022 | 8491 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 121 | 0.110 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 74 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1830 | 0.110 |
Why?
|
| Candida albicans | 1 | 2012 | 32 | 0.100 |
Why?
|
| Leiomyomatosis | 1 | 2012 | 12 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2012 | 72 | 0.100 |
Why?
|
| Humans | 14 | 2023 | 86645 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 3092 | 0.100 |
Why?
|
| Virulence Factors | 1 | 2012 | 108 | 0.100 |
Why?
|
| Phenotype | 3 | 2012 | 2378 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 273 | 0.100 |
Why?
|
| Reperfusion Injury | 1 | 2011 | 131 | 0.090 |
Why?
|
| Metagenome | 1 | 2011 | 102 | 0.090 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 143 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 191 | 0.090 |
Why?
|
| Intestine, Small | 1 | 2011 | 303 | 0.090 |
Why?
|
| Endoleak | 2 | 2021 | 35 | 0.090 |
Why?
|
| Critical Illness | 1 | 2012 | 294 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2011 | 227 | 0.080 |
Why?
|
| Cytokines | 1 | 2012 | 776 | 0.080 |
Why?
|
| Animals | 6 | 2012 | 26582 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2012 | 227 | 0.080 |
Why?
|
| Aged | 5 | 2021 | 18415 | 0.070 |
Why?
|
| Biomarkers | 1 | 2012 | 1718 | 0.070 |
Why?
|
| Registries | 2 | 2021 | 703 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 6509 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 364 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2020 | 2262 | 0.060 |
Why?
|
| Male | 6 | 2021 | 40967 | 0.050 |
Why?
|
| Female | 6 | 2021 | 44534 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2023 | 228 | 0.050 |
Why?
|
| Peru | 1 | 2021 | 24 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2020 | 40 | 0.050 |
Why?
|
| Patient-Specific Modeling | 1 | 2020 | 19 | 0.050 |
Why?
|
| Aneurysm, Ruptured | 1 | 2020 | 51 | 0.050 |
Why?
|
| Vascular Patency | 1 | 2020 | 126 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 5210 | 0.050 |
Why?
|
| Finite Element Analysis | 1 | 2020 | 74 | 0.050 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 98 | 0.050 |
Why?
|
| Aorta | 1 | 2020 | 280 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 107 | 0.040 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2018 | 99 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 2601 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1673 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1054 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 2232 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 943 | 0.030 |
Why?
|
| Middle Aged | 3 | 2020 | 25028 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3680 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 2012 | 33 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2011 | 26 | 0.030 |
Why?
|
| Biofilms | 1 | 2012 | 42 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2011 | 84 | 0.030 |
Why?
|
| Stroke | 1 | 2020 | 965 | 0.030 |
Why?
|
| Microbiological Techniques | 1 | 2011 | 24 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 2012 | 141 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2011 | 72 | 0.020 |
Why?
|
| Drug Design | 1 | 2011 | 124 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 674 | 0.020 |
Why?
|
| Symbiosis | 1 | 2011 | 118 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 2011 | 79 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 319 | 0.020 |
Why?
|
| Color | 1 | 2009 | 81 | 0.020 |
Why?
|
| General Surgery | 1 | 2011 | 229 | 0.020 |
Why?
|
| Iron | 1 | 2009 | 164 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 853 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2009 | 139 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 1538 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1135 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3030 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 3640 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 25648 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 3968 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3362 | 0.010 |
Why?
|